![New global vaccine trial launched to evaluate fractional COVID-19 booster shots - Murdoch Children's Research Institute New global vaccine trial launched to evaluate fractional COVID-19 booster shots - Murdoch Children's Research Institute](https://www.mcri.edu.au/images/news/shutterstock_1935309334_indo_vaccination_centre.jpg)
New global vaccine trial launched to evaluate fractional COVID-19 booster shots - Murdoch Children's Research Institute
![Cambridge begins world-first COVID-19 vaccine booster study - NIHR - Cambridge Clinical Research Facility Cambridge begins world-first COVID-19 vaccine booster study - NIHR - Cambridge Clinical Research Facility](https://www.cambridgecrf.nihr.ac.uk/wp-content/uploads/2023/03/Peter_trial_vacinne_web.png)
Cambridge begins world-first COVID-19 vaccine booster study - NIHR - Cambridge Clinical Research Facility
![Global-first COVID-19 vaccine booster trial launches in Bradford – Bradford Teaching Hospitals NHS Foundation Trust Global-first COVID-19 vaccine booster trial launches in Bradford – Bradford Teaching Hospitals NHS Foundation Trust](https://www.bradfordhospitals.nhs.uk/wp-content/uploads/2021/06/vab.jpg)
Global-first COVID-19 vaccine booster trial launches in Bradford – Bradford Teaching Hospitals NHS Foundation Trust
![Vaccine trial to investigate a booster for teenagers to protect against COVID-19 | Health Care Research Wales Vaccine trial to investigate a booster for teenagers to protect against COVID-19 | Health Care Research Wales](https://healthandcareresearchwales.org/sites/default/files/styles/large/public/2022-05/Patient_arm_vaccination.jpg?h=cea2b766&itok=khadLf6F)
Vaccine trial to investigate a booster for teenagers to protect against COVID-19 | Health Care Research Wales
![Immune response to SARS-CoV-2 after a booster of mRNA-1273: an open-label phase 2 trial | Nature Medicine Immune response to SARS-CoV-2 after a booster of mRNA-1273: an open-label phase 2 trial | Nature Medicine](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41591-022-01739-w/MediaObjects/41591_2022_1739_Fig1_HTML.png)
Immune response to SARS-CoV-2 after a booster of mRNA-1273: an open-label phase 2 trial | Nature Medicine
![News - Major Covid-19 booster trial looks at how best to improve immunity against coronavirus in vulnerable people - University of Nottingham News - Major Covid-19 booster trial looks at how best to improve immunity against coronavirus in vulnerable people - University of Nottingham](https://www.nottingham.ac.uk/PressReleaseLongForm-Images/MHS/Vaccine-combo.xd02a85cc.jpg)